Tuesday June 10
|
| |
|
|
| 08.00 |
|
BTK and CLI: how to succeed? |
| |
|
Moderators: P. Schneider, M. Fusaro, F. Airoldi, E. Puras Mallagray
|
| 08.00 |
|
Developing concepts |
| |
|
08.00 |
|
What do we really know about pedal angiosomes? When is the collateral circulation adequate to heal the foot through indirect revascularization and how do we know when we have done enough? V. Alexandrescu |
| |
|
08.07 |
|
The first commandment of angioplasty for CLI: respect the “landing zone”, R. Ferraresi 
|
| |
|
08.14 |
|
Pedal angioplasty: in which cases does it help and when is it too risky? F. Airoldi |
| |
|
08.21 |
|
Discussion |
| 08.26 |
|
New tools
|
| |
|
08.26 |
|
Tools and options for crossing long tibial occlusions, J. Brunet
|
| |
|
08.33 |
|
Dedicated, self-expanding, drug eluting stent for the BTK arteries: the Stentys device and 6 month trial results, K. Deloose
|
| |
|
08.40 |
|
Is there a place for very distal BTK stenting? What are the options for acute PTA failure?
E. Puras Mallagray
|
| |
|
08.47 |
|
Bifurcated BTK stents: when and how to do it, G. Coppi
|
| |
|
08.54 |
|
Discussion |
| 09.00 |
|
Debate |
| |
|
09.00 |
|
BTK drug coated balloons will eventually solve our problem with CLI, G. Tepe |
| |
|
09.08 |
|
Drug coated balloons are dangerous in CLI. How about PTA or atherectomy with bailout DES when needed? K. Deloose
|
| |
|
09.16 |
|
Discussion |
| 09.20 |
|
Next steps |
| |
|
09.20 |
|
What evidence do we have for an “endo first” approach to CLI? Is it good marketing or good science? P. Schneider |
| |
|
09.28 |
|
These are the trials that need to be done to advance CLI, K. Deloose
|
| |
|
09.36 |
|
Discussion |
| |
|
|
|
|
| 09.50 |
|
Panel discussion |
| 11.15 |
|
Choosing covered stents |
| |
|
Moderators: L. Inglese, C. Rabbia, S. Ronchey |
| |
|
|
| 11.15 |
|
History of covered stents for small and medium size vessels, L. Inglese
|
| 11.25 |
|
Why I prefer to use conventional stents instead of covered stents for renal artery stenosis, C. Rabbia |
| 11.35 |
|
Covered stents vs coiling or in combination for bail out of visceral vessels aneurysms, F. Numan
|
| 11.45 |
|
Covered or semi covered stent for CAS. A glimpse into the future? N. Hopkins |
| 11.55 |
|
Choice of covered stents for chimney, parallel or sandwich procedures, Z. Rancic
|
| 12.05 |
|
World clinical experience with TriVascular Ovation System, Z. Krajcer |
| 12.15 |
|
SFA & POP a. restenosis: is there a role for covered stents? P. Schneider |
| 12.25 |
|
Which type of neointima could we expect after covered stent deployment?
What and how long should we anti aggregate? K. Mathias |
| 12.35 |
|
Discussion |
| |
|
|
| 13.00 |
|
Lunch break: buffet lunch served on the roof top, coffee served in the exhibition hall  |
| 14.00 |
|
CTO management |
| |
|
Moderators: E. Ducasse, M. Farber, P. Schneider, R. Hassen-Khodja |
| |
|
|
| 14.00 |
|
Evidence for endovascular treatment for TASC C and D femoral lesions, K. Deloose
|
| 14.10 |
|
CTO long recanalization: tips and tricks for crossing and re-entry, R. Ferraresi
|
| 14.20 |
|
Retrograde accesses and possibilities for CTO recanalization, E. Ducasse
|
| 14.30 |
|
Long stenting for CTO management, Y. Gouëffic |
| 14.40 |
|
Focal stenting for CTO management, P. Schneider |
| 14.50 |
|
DEB for CTO management, G. Tepe |
| 15.00 |
|
Covered stent for CTO management, F. Verzini
|
| 15.10 |
|
DES for CTO management, P. Commeau
|
| 15.20 |
|
Recanalization management for CTO with previous stent, S. Ronchey |
| 15.30 |
|
Video case of CTO management, A. Sauguet
|
| 15.40 |
|
Discussion |
| |
|
|
| 15.45 |
|
Oral presentations and videos competitions |
| |
|
Jury: J. Busquet, P. Bergeron, G. Tepe
|
| |
|
|
| 15.45 |
|
Oral presentations |
| |
|
15.45 |
|
Endovascular treatment of internal carotid artery aneurysm under protection, Rumas Aslam
|
| |
|
15.50 |
|
Perioperative aortic dissection rupture after endovascular stent graft placement for treatment of type B dissection, Jian-Fang Luo
|
| |
|
15.55 |
|
The application of various devices and techniques in aortic endovascular repair, Xiaodong Li
|
| |
|
16.00 |
|
Compliance with surveillance protocols, following elective endovascular
aneurysm repair, Abigail Morbi
|
| |
|
16.05 |
|
Technical success with a balloon-positioned subintimal crossing device:
subgroup analysis from the Re-ROUTE trial, Koen Keirse
|
| |
|
16.10 |
|
Comparison of venous hemodynamics between conventional surgery
and endovenous LASER ablation (EVLA) in great saphenous varicose veins, Yoongseok Park |
| |
|
16.15 |
|
Silent cerebral infarction following thoracic endovascular aortic repair, Anisha Perera
|
| |
|
16.20 |
|
Complications in endovenous LASER ablation for great saphenous varicose veins,
Yoongseok Park |
| |
|
|
|
|
| 16.30 |
|
Video presentations |
| |
|
16.30 |
|
Tagliatelle technique: a new option in the vascular access of the lower limbs, Benoît Boura |
| |
|
16.35 |
|
Retrograde angioplasty, Mosaad Soliman |
| |
|
16.40 |
|
ICA pseudoaneurysm, Robert Ferguson |
| |
|
|
|
|
| 17.30 |
|
Awards ceremony & Adjournment |
Why I prefer to use conventional stents instead of covered stents for renal artery stenosis
